Xarelto (rivaroxaban)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
WARNINGS AND PRECAUTIONS
Risk of Bleeding
Addition of selective serotonin reuptake inhibitors, and serotonin...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts